Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Cash: 2023-2024

Historic Change in Cash for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $300.3 million.

  • Upstream Bio's Change in Cash rose 288.15% to $26.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year increase of 376.64%. This contributed to the annual value of $300.3 million for FY2024, which is 3318.96% up from last year.
  • Latest data reveals that Upstream Bio reported Change in Cash of $300.3 million as of FY2024, which was up 3,318.96% from $8.8 million recorded in FY2023.
  • Upstream Bio's 5-year Change in Cash high stood at $300.3 million for FY2024, and its period low was $8.8 million during FY2023.
  • Its 2-year average for Change in Cash is $154.5 million, with a median of $154.5 million in 2023.
  • Data for Upstream Bio's Change in Cash shows a peak YoY surged of 3,318.96% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Change in Cash (Yearly) stood at $8.8 million in 2023, then skyrocketed by 3,318.96% to $300.3 million in 2024.